Treatment of Factor VII Deficiency with Recombinant Factor VIla
- 1 January 1996
- journal article
- Published by S. Karger AG in Pathophysiology of Haemostasis and Thrombosis
- Vol. 26 (Suppl. 1) , 155-158
- https://doi.org/10.1159/000217259
Abstract
Factor VII deficiency is a relatively infrequent hereditary bleeding disorder. Recombinant factor VIla has been used to treat patients with factor VII deficiency with bleeding episodes or undergoing surgery. The drug has shown a high efficacy rate and will provide factor VH-deficient patients with a therapeutic agent that is not derived from human plasma.Keywords
This publication has 0 references indexed in Scilit: